IBDEI19Z ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22593,2)
 ;;=^336606
 ;;^UTILITY(U,$J,358.3,22594,0)
 ;;=558.41^^125^1394^28
 ;;^UTILITY(U,$J,358.3,22594,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22594,1,4,0)
 ;;=4^558.41
 ;;^UTILITY(U,$J,358.3,22594,1,5,0)
 ;;=5^Eosinophilic Gastroenteritis
 ;;^UTILITY(U,$J,358.3,22594,2)
 ;;=^336607
 ;;^UTILITY(U,$J,358.3,22595,0)
 ;;=558.42^^125^1394^27
 ;;^UTILITY(U,$J,358.3,22595,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22595,1,4,0)
 ;;=4^558.42
 ;;^UTILITY(U,$J,358.3,22595,1,5,0)
 ;;=5^Eosinophilic Colitis
 ;;^UTILITY(U,$J,358.3,22595,2)
 ;;=^336608
 ;;^UTILITY(U,$J,358.3,22596,0)
 ;;=569.44^^125^1394^25
 ;;^UTILITY(U,$J,358.3,22596,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22596,1,4,0)
 ;;=4^569.44
 ;;^UTILITY(U,$J,358.3,22596,1,5,0)
 ;;=5^Dysplasia of Anus
 ;;^UTILITY(U,$J,358.3,22596,2)
 ;;=^336609
 ;;^UTILITY(U,$J,358.3,22597,0)
 ;;=571.42^^125^1394^59
 ;;^UTILITY(U,$J,358.3,22597,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22597,1,4,0)
 ;;=4^571.42
 ;;^UTILITY(U,$J,358.3,22597,1,5,0)
 ;;=5^Hepatitis,Autoimmune
 ;;^UTILITY(U,$J,358.3,22597,2)
 ;;=^336610
 ;;^UTILITY(U,$J,358.3,22598,0)
 ;;=787.21^^125^1394^21
 ;;^UTILITY(U,$J,358.3,22598,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22598,1,4,0)
 ;;=4^787.21
 ;;^UTILITY(U,$J,358.3,22598,1,5,0)
 ;;=5^Dysphagia,Oral Phase
 ;;^UTILITY(U,$J,358.3,22598,2)
 ;;=^335276
 ;;^UTILITY(U,$J,358.3,22599,0)
 ;;=787.22^^125^1394^22
 ;;^UTILITY(U,$J,358.3,22599,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22599,1,4,0)
 ;;=4^787.22
 ;;^UTILITY(U,$J,358.3,22599,1,5,0)
 ;;=5^Dysphagia,Oropharyngeal
 ;;^UTILITY(U,$J,358.3,22599,2)
 ;;=^335277
 ;;^UTILITY(U,$J,358.3,22600,0)
 ;;=787.23^^125^1394^23
 ;;^UTILITY(U,$J,358.3,22600,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22600,1,4,0)
 ;;=4^787.23
 ;;^UTILITY(U,$J,358.3,22600,1,5,0)
 ;;=5^Dysphagia,Pharyngeal
 ;;^UTILITY(U,$J,358.3,22600,2)
 ;;=^335278
 ;;^UTILITY(U,$J,358.3,22601,0)
 ;;=787.24^^125^1394^24
 ;;^UTILITY(U,$J,358.3,22601,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22601,1,4,0)
 ;;=4^787.24
 ;;^UTILITY(U,$J,358.3,22601,1,5,0)
 ;;=5^Dysphagia,Pharyngoesoph
 ;;^UTILITY(U,$J,358.3,22601,2)
 ;;=^335279
 ;;^UTILITY(U,$J,358.3,22602,0)
 ;;=787.29^^125^1394^20
 ;;^UTILITY(U,$J,358.3,22602,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22602,1,4,0)
 ;;=4^787.29
 ;;^UTILITY(U,$J,358.3,22602,1,5,0)
 ;;=5^Dysphagia NEC
 ;;^UTILITY(U,$J,358.3,22602,2)
 ;;=^335280
 ;;^UTILITY(U,$J,358.3,22603,0)
 ;;=584.9^^125^1395^2
 ;;^UTILITY(U,$J,358.3,22603,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22603,1,4,0)
 ;;=4^584.9
 ;;^UTILITY(U,$J,358.3,22603,1,5,0)
 ;;=5^Acute Renal Failure
 ;;^UTILITY(U,$J,358.3,22603,2)
 ;;=^67114
 ;;^UTILITY(U,$J,358.3,22604,0)
 ;;=583.9^^125^1395^19
 ;;^UTILITY(U,$J,358.3,22604,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22604,1,4,0)
 ;;=4^583.9
 ;;^UTILITY(U,$J,358.3,22604,1,5,0)
 ;;=5^Glomerulonephritis
 ;;^UTILITY(U,$J,358.3,22604,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,22605,0)
 ;;=403.90^^125^1395^51
 ;;^UTILITY(U,$J,358.3,22605,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22605,1,4,0)
 ;;=4^403.90
 ;;^UTILITY(U,$J,358.3,22605,1,5,0)
 ;;=5^Renal Insufficiency with Hypertension (CRI and HTN)
 ;;^UTILITY(U,$J,358.3,22605,2)
 ;;=Renal Insufficiency with Hypertension (CRI and HTN)^269609
 ;;^UTILITY(U,$J,358.3,22606,0)
 ;;=593.9^^125^1395^9
 ;;^UTILITY(U,$J,358.3,22606,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22606,1,4,0)
 ;;=4^593.9
 ;;^UTILITY(U,$J,358.3,22606,1,5,0)
 ;;=5^Chronic Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,22606,2)
 ;;=Chronic Renal Insufficiency^123849
 ;;
 ;;$END ROU IBDEI19Z
